Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evaxion Biotech (EVAX)
NASDAQ:EVAX
Evaxion Biotech (EVAX) Stock Price & Analysis
188 Followers
EVAX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.26 - $13.82
Previous Close$3.15
Volume42.88K
Average Volume (3M)37.87K
Market Cap
$16.42M
Enterprise Value$21.71M
Total Cash (Recent Filing)$5.58M
Total Debt (Recent Filing)$10.87M
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Aug 08, 2024EPS Estimate
-$0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.55
Shares Outstanding3,789,778
10 Day Avg. Volume145,630
30 Day Avg. Volume37,873
Standard Deviation0.23
R-Squared0.00258
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-2.27
Price to Sales (P/S)147.44
Price to Cash Flow (P/CF)N/A
P/FCF Ratio24.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit297.40
Enterprise Value/Ebitda-2.15
Forecast
1Y Price Target
$10.50Price Target Upside234.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Evaxion Biotech News
PremiumCompany Announcements
Evaxion Boosts Vaccine Prediction with AI Advances
PremiumCompany Announcements
Evaxion Biotech Board Member Resigns
PremiumCompany Announcements
Evaxion Biotech Highlights 2024 Successes and Prospects
PremiumCompany Announcements
Evaxion Biotech Advances in Cancer Vaccine Development
PremiumCompany Announcements
Evaxion Biotech Secures Patent Co-Ownership RightsOwnership Overview
0.00%
Insiders
<0.01% Mutual Funds
7.04% Other Institutional Investors
92.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVAX FAQ
What was Evaxion Biotech’s price range in the past 12 months?
Evaxion Biotech lowest stock price was $2.26 and its highest was $13.82 in the past 12 months.
What is Evaxion Biotech’s market cap?
Currently, no data Available
When is Evaxion Biotech’s upcoming earnings report date?
Evaxion Biotech’s upcoming earnings report date is Aug 08, 2024 which is in 22 days.
How were Evaxion Biotech’s earnings last quarter?
Evaxion Biotech released its earnings results on May 28, 2024. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of -$1.095 by $1.125.
Is Evaxion Biotech overvalued?
According to Wall Street analysts Evaxion Biotech’s price is currently Undervalued.
Does Evaxion Biotech pay dividends?
Evaxion Biotech does not currently pay dividends.
What is Evaxion Biotech’s EPS estimate?
Evaxion Biotech’s EPS estimate is -$0.39.
How many shares outstanding does Evaxion Biotech have?
Evaxion Biotech has 5,215,054 shares outstanding.
What happened to Evaxion Biotech’s price movement after its last earnings report?
Evaxion Biotech reported an EPS of $0.03 in its last earnings report, beating expectations of -$1.095. Following the earnings report the stock price went down -5.198%.
Which hedge fund is a major shareholder of Evaxion Biotech?
Currently, no hedge funds are holding shares in EVAX
---
Evaxion Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.50 (234.39% Upside)
$10.50 (234.39% Upside)
Blogger Sentiment
Neutral
EVAX Sentiment 50%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.00%
12-Months-Change
Fundamentals
Return on Equity
-320.15%
Trailing 12-Months
Asset Growth
10.57%
Trailing 12-Months
Company Description
Evaxion Biotech
Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market.
---
EVAX Earnings Call
Q2 2023
0:00 / 0:00
---
EVAX Stock 12 Month Forecast
Average Price Target
$10.50
▲(234.39% Upside)
Technical Analysis
Best Analysts Covering EVAX
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-57.33%
reiterated a buy rating last month
Copying Thomas Flaten's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -57.33% per trade.
---